Showing posts with label Contraceptives Market. Show all posts
Showing posts with label Contraceptives Market. Show all posts

Wednesday, 21 February 2018

Contraceptives Market: Increasing Cases for Sexually Transmitted Infections Rises the Demand

The worldwide contraceptives market is foreseen to experience exceptional competition with the emergence of a huge number of companies that work globally. Nevertheless, Bayer AG sustained as the victorious business in year 2016 ascribed to its several solid worldwide presence and item portfolio. This has supported other key players to create effective and affordable contraception products in coming years.
Some other major firms in the contraceptives market are Cipla Inc., Mankind Pharma, Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Allergan plc, Merck Co. Inc., Pfizer Inc., HLL Lifecare Limited, Reckitt Benckiser plc among the rest of them. Moreover, Pharmaceutical organizations ViiV Healthcare — a worldwide expert HIV organization framed in 2009 through an extraordinary association amongst GSK and Pfizer — and Belgium-based Janssen, have additionally grabbed the nanoparticles and are utilizing them to form a warehouse infusion into the muscle, which means one infusion could give HIV prescriptions to up to 3 months. Though the pediatric and oral plans are still years from making it on to the market, the main injections are in stage II and III clinical trials and may be accessible.
According to Transparency Market Research (TMR) the global contraceptives market is anticipated to grow at a steady CAGR of 6.1% within the forecast period. This figure was evaluated to be worth US$ 22,050 mn in year 2016. This worth is expected to be around US$ 37,242.7 mn by year 2025. On the basis of the key product type, preventative gadgets holds importance with the fragment holding around 53.2% market share in year 2016. Healthcare medical store dominates among the major conveyance channels by through several great elements. Based on geography, North America accounts for interesting development prospects as compared with other major regions for contraceptives. Be that as it may, Asia Pacific is prepared to project the key development pace over the conjecture time frame.
Within the key elements supporting the contraceptives market is the increasing awareness battles that engender contraceptives to act as an innovative technique to anticipate unintended or unplanned pregnancies that is contributing to their expanded reception within youthful and juvenile masses in both developing and developed nations. The movement that are by and large attempted by NGOs and government offices are run by celebrities that is favoring the use of contraceptives within the young crowd who possess the outlook to copy popular people.
In developing areas, mostly within the urban people, sexual desires and current instruction are significant elements for the increased usage of contraceptives. Rise in number of females in the nuclear family setups and worksapce are prompting expanding usage of contraceptives to abort the pregnancies. Moreover, couples are looking for the innovation for prevention to be received and directed with respect to family plans that are convenient for them.
Moreover, the growing number of cases suffering from sexually transmitted infections is likewise encouraging the usage of contraceptives in global market. This is because of the fact that contraceptives, such as, topical prophylactic fix and condoms are successful to avoid or prevent sexually transmitted diseases, such as AIDS times of diseased sexual contacts with different accomplices.
Further, the awareness crusades likewise offer master direction about selection of best strategy for contraception relying upon singular need. Overall health of women, frequency of sexual action, age, will to have kids in future, and family history are a portion of the components that gynecologists investigate before informing the strategy with respect to contraception. Finally, improvement of novel prophylactic items by encouraging reigning players is additionally working in favor for the contraceptives market.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Tuesday, 6 February 2018

Contraceptives Market to be Evaluated at US$ 37,242.7 Million by 2025

According to Transparency Market Research (TMR) the global contraceptives market is anticipated to grow at a steady CAGR of 6.1% within the forecast period. This figure was evaluated to be worth US$ 22,050 mn in year 2016. This worth is expected to be around US$ 37,242.7 mn by year 2025. On the basis of the key product type, preventative gadgets holds importance with the fragment holding around 53.2% market share in year 2016. Healthcare medical store dominates among the major conveyance channels by through several great elements. Based on geography, North America accounts for interesting development prospects as compared with other major regions for contraceptives. Be that as it may, Asia Pacific is prepared to project the key development pace over the conjecture time frame.
Within the key elements supporting the contraceptives market is the increasing awareness battles that engender contraceptives to act as an innovative technique to anticipate unintended or unplanned pregnancies that is contributing to their expanded reception within youthful and juvenile masses in both developing and developed nations. The movement that are by and large attempted by NGOs and government offices are run by celebrities that is favoring the use of contraceptives within the young crowd who possess the outlook to copy popular people.
In developing areas, mostly within the urban people, sexual desires and current instruction are significant elements for the increased usage of contraceptives. Rise in number of females in the nuclear family setups and worksapce are prompting expanding usage of contraceptives to abort the pregnancies. Moreover, couples are looking for the innovation for prevention to be received and directed with respect to family plans that are convenient for them.
Moreover, the growing number of cases suffering from sexually transmitted infections is likewise encouraging the usage of contraceptives in global market. This is because of the fact that contraceptives, such as, topical prophylactic fix and condoms are successful to avoid or prevent sexually transmitted diseases, such as AIDS times of diseased sexual contacts with different accomplices.
Further, the awareness crusades likewise offer master direction about selection of best strategy for contraception relying upon singular need. Overall health of women, frequency of sexual action, age, will to have kids in future, and family history are a portion of the components that gynecologists investigate before informing the strategy with respect to contraception. Finally, improvement of novel prophylactic items by encouraging reigning players is additionally working in favor for the contraceptives market.
The worldwide contraceptives market is foreseen to experience exceptional competition with the emergence of a huge number of companies that work globally. Nevertheless, Bayer AG sustained as the victorious business in year 2016 ascribed to its several solid worldwide presence and item portfolio. This has supported other key players to create effective and affordable contraception products in coming years.
Some other major firms in the contraceptives market are Cipla Inc., Mankind Pharma, Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Allergan plc, Merck Co. Inc., Pfizer Inc., HLL Lifecare Limited, Reckitt Benckiser plc among the rest of them. Moreover, Pharmaceutical organizations ViiV Healthcare — a worldwide expert HIV organization framed in 2009 through an extraordinary association amongst GSK and Pfizer — and Belgium-based Janssen, have additionally grabbed the nanoparticles and are utilizing them to form a warehouse infusion into the muscle, which means one infusion could give HIV prescriptions to up to 3 months. Though the pediatric and oral plans are still years from making it on to the market, the main injections are in stage II and III clinical trials and may be accessible.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Thursday, 1 February 2018

Contraceptives Market to be Evaluated at US$ 37,242.7 Million by the End of 2025

According to Transparency Market Research (TMR) the global contraceptives market is anticipated to grow at a steady CAGR of 6.1% within the forecast period. This figure was evaluated to be worth US$ 22,050 mn in year 2016. This worth is expected to be around US$ 37,242.7 mn by year 2025. On the basis of the key product type, preventative gadgets holds importance with the fragment holding around 53.2% market share in year 2016. Healthcare medical store dominates among the major conveyance channels by through several great elements. Based on geography, North America accounts for interesting development prospects as compared with other major regions for contraceptives. Be that as it may, Asia Pacific is prepared to project the key development pace over the conjecture time frame.


Within the key elements supporting the contraceptives market is the increasing awareness battles that engender contraceptives to act as an innovative technique to anticipate unintended or unplanned pregnancies that is contributing to their expanded reception within youthful and juvenile masses in both developing and developed nations. The movement that are by and large attempted by NGOs and government offices are run by celebrities that is favoring the use of contraceptives within the young crowd who possess the outlook to copy popular people.

In developing areas, mostly within the urban people, sexual desires and current instruction are significant elements for the increased usage of contraceptives. Rise in number of females in the nuclear family setups and worksapce are prompting expanding usage of contraceptives to abort the pregnancies. Moreover, couples are looking for the innovation for prevention to be received and directed with respect to family plans that are convenient for them.

Moreover, the growing number of cases suffering from sexually transmitted infections is likewise encouraging the usage of contraceptives in global market. This is because of the fact that contraceptives, such as, topical prophylactic fix and condoms are successful to avoid or prevent sexually transmitted diseases, such as AIDS times of diseased sexual contacts with different accomplices.


Further, the awareness crusades likewise offer master direction about selection of best strategy for contraception relying upon singular need. Overall health of women, frequency of sexual action, age, will to have kids in future, and family history are a portion of the components that gynecologists investigate before informing the strategy with respect to contraception. Finally, improvement of novel prophylactic items by encouraging reigning players is additionally working in favor for the contraceptives market.

The worldwide contraceptives market is foreseen to experience exceptional competition with the emergence of a huge number of companies that work globally. Nevertheless, Bayer AG sustained as the victorious business in year 2016 ascribed to its several solid worldwide presence and item portfolio. This has supported other key players to create effective and affordable contraception products in coming years.

Some other major firms in the contraceptives market are Cipla Inc., Mankind Pharma, Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Allergan plc, Merck Co. Inc., Pfizer Inc., HLL Lifecare Limited, Reckitt Benckiser plc among the rest of them. Moreover, Pharmaceutical organizations ViiV Healthcare — a worldwide expert HIV organization framed in 2009 through an extraordinary association amongst GSK and Pfizer — and Belgium-based Janssen, have additionally grabbed the nanoparticles and are utilizing them to form a warehouse infusion into the muscle, which means one infusion could give HIV prescriptions to up to 3 months. Though the pediatric and oral plans are still years from making it on to the market, the main injections are in stage II and III clinical trials and may be accessible.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Thursday, 2 February 2017

Contraceptives Market: Major Assests, Incidences of Unintended Pregnancies Rises Demand

Contraceptives, available in the form of drugs and devices, prevent sexually transmitted infections and unintentional pregnancy. Every year on 26th September, the World Contraception Day is celebrated by an alliance of 14 NGOs medical societies, and government organizations. This coalition is funded by Bayer Pharma AG. Such partnerships are predicted to spread awareness about reproductive health and sexually transmitted diseases among the masses.

Obtain the Upcoming Market Trends of Contraceptives at: http://bit.ly/2l3g5UH

The global contraceptives market is segmented on the basis of geography and product type. By geography, the global contraceptives market is divided into Asia Pacific, Europe, North America, and Rest of the World. In 2013, the global market was dominated by North America. Factors such as the high occurrence of unplanned pregnancies, favorable reimbursement policies, and the rising use of contraceptive pills are responsible for the dominance of the North America contraceptives market. Asia Pacific is projected to be the fastest-growing market for contraceptives owing to the growing use of contraceptive pills for pregnancy prevention.

By product type, the global contraceptives market is classified into drugs and devices. The analysts divide the drugs segment into oral contraceptive pills, topical contraceptives, and contraceptive injectable. The devices segment is sub-segmented into male contraceptive devices and female contraceptive devices. Low cost and ease of use make the female contraceptives the dominant segment in the global market. The growing number of unintended pregnancies, especially in rural areas, has propelled the demand for various contraceptives.

Leading companies such as Actavis, Inc., Church & Dwight, Co., Inc., Mayer Laboratories, Inc., Reckitt Benckiser plc, Teva Pharmaceutical Industries Ltd., CooperSurgical, Inc., and The Female Health Company are expected to introduce new male contraceptive devices and female contraceptives in the global market to maintain their dominance. Mergers and acquisitions are also likely to help leading companies spread awareness of using contraceptives.

Going forward, factors such as the presence of many contraceptive pipeline products and the entry of new companies can be held responsible for the growth of the global contraceptives market. However, a few factors may restrict the growth of the market, predict the analysts. As per the findings of the research, side effects of contraceptives encourage people to try natural contraceptive methods. Moreover, the rising occurrence of infertility amongst women is restricting the use of contraceptives. Social and ethical issues are also expected to restrict the use of contraceptive products in the near future.

 Read Present Market Status of Contraceptives at: http://www.transparencymarketresearch.com/contraceptives-market.html

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Posted by at No comments:
Labels:

Tuesday, 27 December 2016

Increasing Need to Prevent Sexually Transmitted Diseases Steers Rise of Contraceptives Market

Contraceptives are defined as drugs and devices that help in preventing pregnancy. These devices also prevent spreading of sexually transmitted infection. Various awareness initiatives taken by market players is the major factor propelling the growth of contraceptives market. Bayer HealthCare, a major player in the contraceptives market, in coalition with 11 NGOs, organizes the World Contraception Day every year on September 26 to spread awareness about contraceptive methods, enabling young people to take right decision about their reproductive health.

 Future Analysis and Trends for Contraceptives Market is available at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344

This report provides in-depth analysis of the global contraceptives drugs and devices market. The stakeholders for this report include companies involved in the research and development, manufacturing and commercialization of contraceptive drugs and devices, suppliers and new entrants who are planning to invest in this market. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition for different contraceptive drugs and devices in four major geographies.

The market overview section of this report analyzes market dynamics such as drivers, restraints and opportunities that influence the contraceptives market in the current and future scenario. Further, Porter’s five forces analysis and market attractiveness analysis have been included in market overview section in order to explain the intensity of competition in the market. Porter’s five forces analysis is also elucidated in the section to understand the attractiveness of the contraceptive market in terms of five different attributes that have an effect on the sustenance of the players in the contraceptives market. Competitive scenario among the market players is analyzed through a heat map of major market players in the competitive landscape section of the report. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in the global market.

Based on the product types, the global contraceptives market is segmented into two major segments, namely, contraceptive drugs and contraceptive devices. Contraceptive drugs are further categorized into three segments including contraceptive pills, contraceptive injectables and topical contraceptives. Contraceptives devices segment is also further classified into two segments, male contraceptive devices and female contraceptive devices. Male contraceptive devices segment includes male condoms while female contraceptive devices are further differentiated into female condoms, intrauterine devices (IUDs), contraceptive sponges, contraceptive vaginal rings, subdermal contraceptive implants, contraceptive diaphragms and non-surgical permanent contraceptive devices. IUDs market is further segmented into copper IUD and hormonal IUD. Market revenue in terms of USD million for the period 2012 to 2020 along with the compound annual growth rate (CAGR %) from 2014 to 2020 is analyzed for the various types of contraceptive drugs and devices, considering 2013 as the base year.

Geographically, the contraceptives market has been differentiated into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section of the report provides market estimation in terms of revenue (USD million) of contraceptives market in these four regions from 2012 to 2020. Market revenue for contraceptive drugs and devices is also provided for geographies along with CAGR % for period 2014 to 2020, considering 2013 as the base year.

Read the Present Market Status of Contraceptives at: http://www.transparencymarketresearch.com/contraceptives-market.html

This report also includes recommendations section that will assist new companies in establishing their presence and market players in expanding their market share in the contraceptives market. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Actavis, Inc., Bayers AG, Church & Dwight, Co., Inc., CooperSurgical, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd. and The Female Health Company. 

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Posted by at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)